ArticleiMetaOmics2026
The evolutionary landscape and serotypic dynamics of avian infectious bronchitis virus from spike protein.
Article in iMetaOmics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Avian infectious bronchitis virus (IBV), a gammacoronavirus with substantial agricultural impact, offers a tractable model for dissecting coronavirus evolution. Here, we integrated 20 years of epidemiological surveillance with whole-genome sequence analysis of 624 IBV strains, including 136 newly isolated field samples, to investigate the evolutionary and structural dynamics of N-linked glycosylation at the spike protein. We identified three dominant glycosylation haplotypes defined by residues 51 and 77 of spike protein, which correlate with receptor-binding interfaces, clinical phenotypes, and spatiotemporal transmission patterns. Molecular modeling and docking analyses provided insights into potential mechanistic links between glycan positioning and Neu5Acα2-3Galβ1-3GlcNAc receptor engagement. Complementing these findings, we developed a proof-of-concept machine learning model that shows potential for predicting clinical serotypes directly from the spike protein sequence, achieving high accuracy on a preliminary independent validation set. These findings support the use of glycosylation motifs as structural-genomic markers and highlight the potential of sequence-based serotype prediction. Our work establishes a scalable genomic-structural framework that leverages glycosylation motifs and sequence features as evolutionary markers, providing a powerful approach for forecasting coronavirus adaptation and informing vaccine design and outbreak preparedness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.